Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail

 Kepivance (Palifermin Growth Factor)
Company:  Amgen, Inc.
Application No.:  125103
Approval Date: 12/15/2004


Date created: September 262005

Back to Top    Drugs@FDA


Note: Documents in PDF format require the Adobe Acrobat Reader®.